Graeme Ladds, Director of PharSafer, has over 30 years’ experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, he went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his consultancy and specialist CRO company, PharSafer Associates Ltd, where he has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
Training format
Topic
Live online
This two-day programme will give you a comprehensive review of signal detection and regulatory expectations including the new updated Signal Module IX and Eudravigilance quantitative signal requirement
Live online
This programme will be of interest to all personnel involved in business development and licensing agreements aspects of pharmacovigilance
Live online
In this one-day course, understand everything from the role of medical information to the guidelines for medical information and advertising.
Live online
A practical guide to understanding the role of pharmacovigilance.
New for 2025
Live online
This course has been designed for those wishing to expand their knowledge in pharmacovigilance and explore what they would like to understand next in this complex area.
Live online
This course will provide a comprehensive overview of cosmetogivilance in Europe, the USA and the Rest of the World (ROW). It will provide key guidance for manufacturers and distributors on how to comply with the regulatory requirements, and will be valuable for pharmaceutical and medical device companies looking to access the cosmetic market.
Updated for 2025
Live online
Practical guidance on how to comply with the pharmacovigilance requirements in the Middle East
Live online
This course provides a practical guide to both producing and maintaining the PSMF to ensure compliance and has been fully revised to include the latest updates.
Live online
This course provides a comprehensive overview of key post-market pharmacovigilance activities required as the foundation for further understanding of new EU legislation that was introduced in 2012 and has undergone over 20 updates in the last ten years.
Live online
Understand the relationship between RMPs and safety reviews; PBRERs/DSURs; licence submissions (CTD) and their maintenance.
Live online, Classroom
This course will be of maximum benefit to those drug safety professionals who are working both in the clinical and post-marketing safety arena including QA for auditing.
Live online
This course is designed to help understand pharmacovigilance quality management systems (QMS) and risk-based audits.
Cookies: we use cookies to deliver the best experience to you and to help us understand our customers.
We set the following types of cookies; please set your preference as to which you consent to accepting:
Read our cookie policy
These cookies are essential to correct operation of the website, such as allowing you to log in and purchase. They are used only on this site.
We use Google Analytics to allow us to better understand the type of visitors to our site and their activity. Enabling this should not shape or alter your browsing experience on other websites.
Marketing cookies help us to be more targeted with our online advertising to deliver more relevant content. Enabling this may make you more likely to see adverts from us on other websites.